Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC

Clinical trial NCT00602030 · COMPLETED

Trial details

NCT number: NCT00602030
Sponsor: Syndax Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small-Cell Lung Carcinoma Carcinoma, Non-Small Cell Lung

Start date: 2008-01-08
Primary completion: 2010-02-04
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.